DocGo backs FY25 revenue view of $300M-$330M, consensus $.

FY25 revenue is expected to be $300M-$330M, unchanged from the last quarter. FY25 adjusted EBITDA is expected to be a loss of $20M-$30M, unchanged from the last quarter. Norm Rosenberg, Chief Financial Officer of DocGo (DCGO), commented, “Our total cash balance increased substantially to $128.7 million during the quarter as we continue to collect on our migrant related receivables. Our combined outstanding migrant-related receivables now total approximately $54 million, and we continue to believe that those amounts will be collected over the remainder of the year.” Rosenberg continued, “We also made considerable progress reducing our SG&A during the quarter, making cuts to corporate overhead that will result in an estimated $10 million in annual savings. Our SG&A is neither fixed, nor is it tied to long-term commitments – we’ve identified additional areas for cost savings and we are taking concrete steps in Q3 and Q4 to further reduce our SG&A base. We believe that continuing to right-size our staffing levels and aggressively managing our vendor costs, coupled with our strong pipeline and anticipated growth, will enable us to achieve profitability in the second half of 2026.”